Cme Group Inc 's Revenue in the fiscal year 2025 $ 6,520.60 millions
Cme Group Inc 's Revenue in the fiscal year 2024 $ 6,130.10 millions
Cme Group Inc 's Revenue in the fiscal year 2023 $ 5,578.90 millions
Cme Group Inc 's Revenue in the fiscal year 2022 $ 5,019.40 millions
Cme Group Inc 's Revenue in the fiscal year 2021 $ 4,689.70 millions
CME Revenue second quarter 2026 Y/Y Growth Comment
Cme Group Inc reported Revenue growth of 0.84% year on year in the second quarter 2026, to $ 1,706.20 millions, this is lower than Cme Group Inc 's recent average Revenue increase of 12.03%.
Looking into second quarter 2026 results within Investment Services industry 66 other companies have achieved higher Revenue growth. While Cme Group Inc ' s Revenue increase of 0.84% ranks overall at the positon no. 2361 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Cme Group Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
51.7 %
3.27 %
-22.32 %
(Sep. 30, 2007)
CME's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Cme Group Inc disclosed drop in Revenue from the first quarter by -9.25% to $ 1,706.20 millions, from $ 1,880.10 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Investment Services's company achievement, Most analysts pointed out.
Within Investment Services industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Cme Group Inc 's Revenue growth quarter on quarter, overall rank is 2819.
In the II. Quarter 2026 Cme Group Inc disclosed drop in Revenue from the first quarter by -9.25% to $ 1,706.20 millions, from $ 1,880.10 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Investment Services's company achievement, Most analysts pointed out.
Within Investment Services industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Cme Group Inc 's Revenue growth quarter on quarter, overall rank is 2819.
Cme Group Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 6,772.60
$ 6,758.40
$ 6,520.60
$ 6,397.20
$ 6,444.00
Y / Y Revenue Growth (TTM)
5.1 %
7.54 %
6.37 %
5.84 %
11.15 %
Year on Year Revenue Growth Overall
Ranking
# 1392
# 56
# 771
# 969
# 983
Seqeuential Revenue Change (TTM)
0.21 %
3.65 %
1.93 %
-0.73 %
2.54 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2361
# 154
# 1420
# 1758
# 1676
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Cme Group Inc 's cumulative twelve months Revenue were $ 6,773 millions, company would post below average annual Revenue growth of 2.54% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Cme Group Inc 's Revenue growth from the 1880.1% growth in Mar 31 2026.
In the Financial sector 350 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 56 to 1392.
With the quarterly Revenue reported in the Jun 30 2026 period, Cme Group Inc 's cumulative twelve months Revenue were $ 6,773 millions, company would post below average annual Revenue growth of -11.43% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Cme Group Inc 's Revenue growth from the 1880.1% growth in Mar 31 2026.
In the Financial sector 350 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 56 to 1392.
About Cme Group Inc Revenue Growth Rates (CME), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1.45%